SCHEMBL29248792

SCHEMBL29248792

Cn1c(=O)ccc2c(-c3ccc(CNS(=O)(=O)OC(N)=O)cc3)ccnc21

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ENPP1 P22413 8/20 0.44
▸ ENPP3 O14638 1/20 0.44
▸ CHUK O15111 7/20 0.33
▸ CAMKK2 Q96RR4 3/20 0.33
▸ INSR P06213 2/20 0.33
▸ MAPK8 P45983 2/20 0.33
▸ NEK1 Q96PY6 3/20 0.32
▸ IKBKB O14920 5/20 0.32
▸ ROCK1 Q13464 2/20 0.32
▸ CAMKK1 Q8N5S9 1/20 0.32
▸ CSF1R P07333 1/20 0.31
▸ KIT P10721 1/20 0.31
▸ BLK P51451 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26679894 0.85 ENPP1 (0.56) ENPP1ENPP3CHUKIKBKBROCK1
SCHEMBL29691468 0.85 ENPP1 (0.56) ENPP1ENPP3CHUKIKBKBROCK1
SCHEMBL26680004 0.83 ENPP1 (0.40) ENPP1ENPP3CHUKCAMKK2INSR
SCHEMBL29691648 0.82 CA12 (0.51) ENPP1ENPP3NEK1
SCHEMBL24600500 0.82 CA12 (0.51) ENPP1ENPP3NEK1
SCHEMBL29248789 0.80 CAMKK2 (0.35) ENPP1ENPP3CHUKCAMKK2INSR
SCHEMBL26679830 0.80 ENPP1 (0.38) ENPP1ENPP3CHUKCAMKK2INSR
SCHEMBL29248809 0.80 ENPP1 (0.43) ENPP1ENPP3CHUKCAMKK2INSR
SCHEMBL29691523 0.77 GRM2 (0.46) —
SCHEMBL24600607 0.77 GRM2 (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116669726-A Novel naphthyridinone derivatives having inhibitory activity against exonuclease-phosphodiesterase and use thereof 谛希诺生物科技有限公司 2023-08-29 — — CN claimed
CN-116669726-A Novel naphthyridinone derivatives having inhibitory activity against exonuclease-phosphodiesterase and use thereof 谛希诺生物科技有限公司 2023-08-29 — — CN disclosed
Send feedback